李 柏增

Medicine & Life Sciences

1. Tachycardia 100%
2. Atrial Fibrillation 97%
3. Ventricular Premature Complexes 87%
4. Peripheral Arterial Disease 81%
5. Catheters 71%
6. Cicatrix 63%
7. Cyclophilin A 55%
8. Proprotein Convertases 54%
9. Proprotein Convertase 9 53%
10. Cilostazol 53%
11. Atrial Premature Complexes 53%
12. Subtilisin 52%
13. Mortality 49%
14. Randomized Controlled Trials 49%
15. Hyperlipoproteinemia Type II 45%
16. Catheter Ablation 42%
17. ST Elevation Myocardial Infarction 40%
18. Coronary Artery Disease 38%
19. Chronic Renal Insufficiency 37%
20. Lead 37%
21. Angioplasty 36%
22. Catheterization 35%
23. Cause of Death 33%
24. Thoracic Surgery 32%
25. Pulmonary Veins 32%
26. Prostheses and Implants 32%
27. Arteries 27%
28. Extremities 27%
29. Stem Cells 26%
30. Cardiovascular Diseases 26%
31. Stents 25%
32. Anti-Bacterial Agents 24%
33. Exercise 23%
34. Inflammation 23%
35. Confidence Intervals 21%
36. Safety 21%
37. Coronary Vessels 20%
38. Infections 20%
39. Electrocardiography 20%
40. Population 20%
41. Bradycardia 19%
42. Elderly 18%
43. Cardiac Electrophysiologic Techniques 17%